Redefining Therapeutic Paradigms for Microtubule Inhibitors

Physicians Education Resource
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
Course Content
Satellite symposium will highlight advances in the use of novel cytotoxic agents for the treatment of metastatic breast cancer (MBC), non–small-cell lung cancer (NSCLC), pancreatic cancer, and melanoma. Recent data indicate that novel taxane formulations and other microtubule-interacting agents might improve the therapeutic index in MBC and NSCLC. In addition, these agents are demonstrating activity in melanoma and pancreatic cancer, malignancies that have been resistant to traditional...
Learning objectives, training objectives
Please see our websie for all the details
Target Audience
medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer, NSCLC, pancreatic cancer, and melanoma. Fellows, nurse practitioners, nurses, physician assistants, practitioners, nurses, physician assistants

Enquiries and Registration:

Mr. Duane Fowler
no registration fee
Organizer contact info
3500 Maple Ave. Ste. 700
75219 Dallas
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation European Health Forum GasteinnewTreeAMREF - African Medical and Research FoundationAnästhesie in Entwicklungsländern e. V.Österreichisches Rotes KreuzAlumni Club Medizinische Universität WienHelix - Forschung & Beratung Wien